0001104659-19-008738.txt : 20190214 0001104659-19-008738.hdr.sgml : 20190214 20190214162041 ACCESSION NUMBER: 0001104659-19-008738 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 EFFECTIVENESS DATE: 20190214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Samsara BioCapital, LLC CENTRAL INDEX KEY: 0001744967 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19375 FILM NUMBER: 19606695 BUSINESS ADDRESS: STREET 1: 628 MIDDLEFIELD ROAD CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 285-4270 MAIL ADDRESS: STREET 1: 628 MIDDLEFIELD ROAD CITY: PALO ALTO STATE: CA ZIP: 94301 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001744967 XXXXXXXX 12-31-2018 12-31-2018 false Samsara BioCapital, LLC
628 Middlefield Road Palo Alto CA 94301
13F HOLDINGS REPORT 028-19375 N
Richard Van Doren Chief Compliance Officer 650-285-4270 /s/ Richard Van Doren Palo Alto CA 02-14-2019 0 17 104184 false
INFORMATION TABLE 2 a19-4733_1informationtable.xml INFORMATION TABLE Allakos Inc COM 01671P100 23959 458366 SH SOLE 458366 0 0 Aravive Inc COM 03890D108 1558 442733 SH SOLE 442733 0 0 Catabasis Pharmaceuticals Inc COM 14875P206 1311 300000 SH SOLE 300000 0 0 Edge Therapeutics Inc COM 279870109 59 183332 SH SOLE 183332 0 0 Evelo Biosciences Inc COM 299734103 2960 227529 SH SOLE 227529 0 0 Intercept Pharmaceuticals Inc COM 45845P108 23623 234375 SH SOLE 234375 0 0 KalVista Pharmaceuticals Inc COM 483497103 2963 150000 SH SOLE 150000 0 0 Liquidia Technologies Inc COM 53635D202 8197 378420 SH SOLE 378420 0 0 Millendo Therapeutics Inc COM 60040X103 359 45101 SH SOLE 45101 0 0 Miragen Therapeutics Inc COM 60463E103 2755 909090 SH SOLE 909090 0 0 Odonate Therapeutics Inc COM 676079106 8390 595850 SH SOLE 595850 0 0 Principia Biopharma Inc COM 74257L108 10504 383480 SH SOLE 383480 0 0 Surface Oncology Inc COM 86877M209 332 78300 SH SOLE 78300 0 0 Sutro BioPharma Inc COM 869367102 10153 1125576 SH SOLE 1125579 0 0 Syros Pharmaceuticals Inc COM 87184Q107 5904 1059938 SH SOLE 1059938 0 0 Trillium Therapeutics Inc COM 89620X506 122 71619 SH SOLE 71619 0 0 Urovant Sciences Ltd COM G9381B108 1038 157480 SH SOLE 157480 0 0